Table 3.
Information on the MLa prediction model development, validation, and performance, and on the severity of illness score performance.
| Author | ML model type (AUROCb test) | Data training/test (split %) | Features | K-fold/validation | External validation data set | ML AUROC external | Severity of illness score model type (AUROC) |
| Pirracchio et al, 2015 [1] |
|
24,508 | 17 | 5-fold cross-validation | 200 | 0.94 |
|
| Nielsen et al, 2019 [24] |
|
10,368 (80/20) |
44 | 5-fold cross-validation | 1528 | 0.773 |
|
| Nimgaonkar et al, 2004 [25] |
|
2962 (70/30) |
15 | N/Ah | N/A | N/A |
|
| Xia et al, 2019 [26] |
|
18,415 (90/10) |
50 | Bootstrap and RSMk | N/A | N/A |
|
| Purushotham et al, 2018 [27] |
|
35,627 | 17/22/ 136 |
5-fold cross-validation | External benchmark | N/A |
|
| Nanayakkara et al, 2018 [28] |
|
39,560 (90/10) |
29 | 5-fold cross-validation | N/A | N/A |
|
| Meyer et al, 2018 [29] |
|
5898 (90/10) |
52 | 10-fold cross-validation | 5989 | 0.81 |
|
| Meiring et al, 2018 [7] |
|
80/20 | 25 | 21,911 LOOn |
N/A | N/A |
|
| Lin et al, 2019 [30] |
|
19,044 | 15 | 5-fold cross-validation | N/A | N/A |
|
| Krishnan et al, 2018 [31] |
|
10,155 (75/25) |
1 | 10-fold cross-validation | N/A | N/A |
|
| Kang et al, 2020 [32] |
|
1571 (70/30) |
33 | 10-fold cross-validation | N/A | N/A |
|
| Johnson et al, 2013 [33] |
|
39,070 (80/20) |
10 | 10-fold cross-validation | 23,618 | 0.837 (univariate); 0.868 (multivariate) |
|
| Holmgren et al, 2019 [34] |
|
217,289 (80/20) |
8 | 5-fold cross-validation | N/A | N/A |
|
| Garcia-Gallo et al, 2020 [35] |
|
5650 (70/30) |
18 140 37 |
10-fold cross-validation | N/A | N/A |
|
| El-Rashidy et al, 2020 [36] |
|
10,664 (75/25) |
80 | 10-fold cross-validation | External benchmark | N/A |
|
| Silva et al, 2006 [37] |
|
13,164 (66/33) |
12 | Hold out | N/A | N/A |
|
| Caicedo-Torres et al, 2019 [38] |
|
22,413 | 22 | 5-fold cross-validation | N/A | N/A |
|
| Deshmukh et al, 2020 [39] |
|
5691 (80/20) |
34 | 5-fold cross-validation | N/A | N/A |
|
| Ryan et al, 2020 [40] |
|
35,061 (80/20) |
12 | 5-fold cross-validation | 114 | 0.91 |
|
| Mayaud et al, 2013 [41] |
|
2113 (70/30) |
25 | BBCCVw | N/A | N/A |
|
aML: machine learning.
bAUROC: area under the receiver operating curve.
cSICULA: Super ICU Learner Algorithm.
dSAPS: Simplified Acute Physiology Score.
eAPACHE: Acute Physiology and Chronic Health Evaluation.
fSOFA: Sequential Organ Failure Assessment.
gNN: neural network.
hN/A: not applicable.
iLSTM: long short-term memory.
jDT: decision tree.
kRSM: random subspace method.
lSVM: support vector machine.
mGBM: gradient boosting machine.
nLOO: leave one out.
oELM: extreme learning machine.
pAPS: Acute Physiology Score.
qk-NN: k-nearest neighbor.
rLR: logistic regression.
sSGB-LASSO: stochastic gradient boosting least absolute shrinkage and selection operator.
tXGB: extreme gradient boosting.
uqSOFA: Quick Sequential Organ Failure Assessment.
vGA: genetic algorithm.
wBBCV: bootstrap bias–corrected cross-validation.